PharmAust Subsidiary Epichem Awarded National Grant to Decarbonise Plastics Recycling
The SmallCaps website reported that clinical-stage biotechnology company PharmAust wholly-owned subsidiary Epichem has been awarded a $45,200 grant from National Energy Resources Australia to advance a carbon-neutral solution for recycling plastic waste. The funding has been provided under the GeneratER Open Innovation Challenge Program and will help Epichem develop an oxidative hydrothermal dissolution pilot program for application by a multinational oil and gas energy client.
Click here to read the full article.